메뉴 건너뛰기




Volumn 1139, Issue , 2014, Pages 45-56

Tumor Antigen-/Cytokine-Pulsed dendritic cells in therapy against lymphoma

Author keywords

Adoptive cell transfer; Antigens; Cytokines; Dendritic cells; IL 15; Kaplan Meier survival curve; Tumor metastasis

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOLOGICAL ADJUVANT; RECOMBINANT INTERLEUKIN 15; TUMOR ANTIGEN; INTERLEUKIN 15;

EID: 84909633566     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-0345-0_6     Document Type: Article
Times cited : (3)

References (19)
  • 1
    • 0036083905 scopus 로고    scopus 로고
    • Exploiting dendritic cells to improve vaccine efficacy
    • Steinman RM, Pope M (2002) Exploiting dendritic cells to improve vaccine efficacy. J Clin Invest 109:1519-1526
    • (2002) J Clin Invest , vol.109 , pp. 1519-1526
    • Steinman, R.M.1    Pope, M.2
  • 2
    • 0035839039 scopus 로고    scopus 로고
    • Dendritic cells as vectors for therapy
    • Banchereau J et al (2001) Dendritic cells as vectors for therapy. Cell 106:271-274
    • (2001) Cell , vol.106 , pp. 271-274
    • Banchereau, J.1
  • 3
    • 0031941423 scopus 로고    scopus 로고
    • Vaccination of melanoma patients with peptideor tumor lysatepulsed DCs
    • Nestle FO et al (1998) Vaccination of melanoma patients with peptideor tumor lysatepulsed DCs. Nat Med 4:328-332
    • (1998) Nat Med , vol.4 , pp. 328-332
    • Nestle, F.O.1
  • 4
    • 0032754286 scopus 로고    scopus 로고
    • Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
    • Dhodapkar MV et al (1999) Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. J Clin Invest 104:173-180
    • (1999) J Clin Invest , vol.104 , pp. 173-180
    • Dhodapkar, M.V.1
  • 5
    • 0035990375 scopus 로고    scopus 로고
    • Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity
    • Zhou Y et al (2002) Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity. J Immunother 25:289-303
    • (2002) J Immunother , vol.25 , pp. 289-303
    • Zhou, Y.1
  • 6
    • 0037388367 scopus 로고    scopus 로고
    • TRANCE-and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients
    • Schlienger K et al (2003) TRANCE-and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients. Clin Cancer Res 9(4):1517-1527
    • (2003) Clin Cancer Res , vol.9 , Issue.4 , pp. 1517-1527
    • Schlienger, K.1
  • 7
    • 67649118309 scopus 로고    scopus 로고
    • Cellular immu-notherapy for ovarian cancer
    • Martin JC, O'Brien TJ (2009) Cellular immu-notherapy for ovarian cancer. Expert Opin Biol Ther 9(6):677-688
    • (2009) Expert Opin Biol Ther , vol.9 , Issue.6 , pp. 677-688
    • Martin, J.C.1    O'brien, T.J.2
  • 8
    • 0037244743 scopus 로고    scopus 로고
    • Rational approaches to human cancer immunotherapy
    • Davis ID et al (2003) Rational approaches to human cancer immunotherapy. J Leukoc Biol 73:3-29
    • (2003) J Leukoc Biol , vol.73 , pp. 3-29
    • Davis, I.D.1
  • 9
    • 33746012881 scopus 로고    scopus 로고
    • Placebo-controlled phase III trial of immunologic therapy with sipuleu-cel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer
    • Small EJ et al (2006) Placebo-controlled phase III trial of immunologic therapy with sipuleu-cel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer. J Clin Oncol 24:3089-3094
    • (2006) J Clin Oncol , vol.24 , pp. 3089-3094
    • Small, E.J.1
  • 10
    • 41249098967 scopus 로고    scopus 로고
    • Dendritic cell vaccines in melanoma: From promise to proof?
    • Lesterhuis WJ et al (2008) Dendritic cell vaccines in melanoma: from promise to proof? Crit Rev Oncol Hematol 66(2):118-134
    • (2008) Crit Rev Oncol Hematol , vol.66 , Issue.2 , pp. 118-134
    • Lesterhuis, W.J.1
  • 11
    • 11244313924 scopus 로고    scopus 로고
    • Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions
    • Neves AR et al (2005) Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions. Cancer Immunol Immunother 54:61-66
    • (2005) Cancer Immunol Immunother , vol.54 , pp. 61-66
    • Neves, A.R.1
  • 12
    • 0034957450 scopus 로고    scopus 로고
    • The allogeneic response and tumor immunity
    • Fabre JW (2001) The allogeneic response and tumor immunity. Nat Med 7:649-652
    • (2001) Nat Med , vol.7 , pp. 649-652
    • Fabre, J.W.1
  • 13
    • 19944428075 scopus 로고    scopus 로고
    • Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: Characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells
    • Suzuki T et al (2005) Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity: characteristics of syngeneic and allogeneic antigen-presenting cell cancer hybrid cells. Clin Cancer Res 11:58-66
    • (2005) Clin Cancer Res , vol.11 , pp. 58-66
    • Suzuki, T.1
  • 14
    • 34247635231 scopus 로고    scopus 로고
    • Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma
    • Yasuda T et al (2007) Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma. Cancer Immunol Immunother 56:1025-1036
    • (2007) Cancer Immunol Immunother , vol.56 , pp. 1025-1036
    • Yasuda, T.1
  • 15
    • 71149113856 scopus 로고    scopus 로고
    • Innate immune defense in visceral leishmaniasis: Cytokine mediated protective role by allogeneic effector cell
    • Manna PP et al (2010) Innate immune defense in visceral leishmaniasis: cytokine mediated protective role by allogeneic effector cell. Vaccine 28:803-810
    • (2010) Vaccine , vol.28 , pp. 803-810
    • Manna, P.P.1
  • 16
    • 0036697306 scopus 로고    scopus 로고
    • Human dendritic cell mediated cytotoxicity against breast carcinoma cells in vitro
    • Manna PP, Mohanakumar T (2002) Human dendritic cell mediated cytotoxicity against breast carcinoma cells in vitro. J Leukoc Biol 72(2):312-320
    • (2002) J Leukoc Biol , vol.72 , Issue.2 , pp. 312-320
    • Manna, P.P.1    Mohanakumar, T.2
  • 17
    • 0037378747 scopus 로고    scopus 로고
    • The mechanism of CD47-dependent killing of T cells: Hetero-trimeric Gi -dependent inhibition of protein kinase A
    • Manna PP, Frazier WA (2003) The mechanism of CD47-dependent killing of T cells: hetero-trimeric Gi -dependent inhibition of protein kinase A. J Immunol 170:3544-3553
    • (2003) J Immunol , vol.170 , pp. 3544-3553
    • Manna, P.P.1    Frazier, W.A.2
  • 19
    • 33845382806 scopus 로고
    • Non-parametric estimation from incomplete observations
    • Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.